✦ LIBER ✦

O-87 Duration of chemotherapy and survival in advanced non-small cell lung cancer (NSCLC). A multicenter, prospective randomised study

✍ Scribed by Andresen, Olga; Sörenson, Sverre; Bergman, Bengt; Sundstrøm, Stein; Vilsvik, Jan; Aasebø, Ulf; Bremnes, Roy; Gilleyrd, Mona

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immediate or delayed radiotherapy in adv

✍ Stein Sundstrøm; Roy Bremnes; Paal Brunsvig; Ulf Aasebø; Olbjørn Klepp; Peter M. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Patient attitudes towards chemotherapy a

✍ Chu, Da-Tong; Kim, Sang-We; Hsu, Hon-Ki; Çok, Gürsel; Roubec, Jaromir; Patil, Sh 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 166 KB

9089 Optimal duration of 1st- and 2nd-li

✍ Grossi, F.; Belvedere, O.; Defferrari, C.; Massoni, C.; Follador, A.; Rijavec, E 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 64 KB

O-117 A pilot study of influences on che

✍ Price, Allan; Higgins, Geoffrey C. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 193 KB

O-143 Gemcitabine-oxaliplatin (GEMOX) ch

✍ Crino, Lucio; Novello, Silvia; De Marinis, Filippo; Maur, Michela; Scagliotti, G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Improving Survival and Reducing Toxicity

✍ Blackhall, Fiona H; Shepherd, Frances A; Albain, Kathy S 📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 172 KB